News from eli lilly and company A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

13:00 ET
Eli Lilly and Company logo.

Lilly and Incyte Announce Webcast to Discuss Baricitinib Phase III Data

Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (Nasdaq: INCY) will host a webcast on June 11 to discuss data from the first two pivotal...

08:30 ET
Eli Lilly and Company logo

PROCLAIM Final Trial Results to be Presented at ASCO Annual Meeting

 Eli Lilly and Company (NYSE: LLY) announced final results of the Phase III PROCLAIM trial that will also be discussed in an oral presentation...

08:00 ET
Eli Lilly and Company logo.

Lilly to Present CYRAMZA® (ramucirumab) Data at 2015 ASCO Annual Meeting

 Eli Lilly and Company (NYSE: LLY) announced that data from several trials of CYRAMZA® (ramucirumab) will be presented at the American...

08:00 ET
Eli Lilly and Company logo

Lilly Announces the Early Results of Its Cash Tender Offer

 Eli Lilly and Company (NYSE: LLY) announced today that pursuant to its previously announced cash tender offer for up to $1.6 billion aggregate...

May 27, 2015, 10:45 ET
Eli Lilly and Company logo.

Lilly Sends Employees to Serve in Vulnerable Communities around the World

 Marcio Donatelli, a senior marketing associate with the animal health division of Eli Lilly and Company (NYSE: LLY), believes his volunteer...

May 27, 2015, 08:30 ET
Humalog 200 units / mL KwikPen

U.S. Food and Drug Administration Approves Humalog® 200 units/mL KwikPen®

 The U.S. Food and Drug Administration (FDA) has approved Humalog® 200 units/mL KwikPen® (insulin lispro 200 units/mL; U-200), a...

May 27, 2015, 07:30 ET
Eli Lilly and Company logo.

Boehringer Ingelheim and Lilly Diabetes Alliance to Present Data from 35 Studies at the American Diabetes Association's 75th Scientific Sessions®

 The presentation of 35 abstracts will demonstrate the breadth and depth of the Boehringer Ingelheim (BIPI) and Eli Lilly and Company (NYSE:...

May 27, 2015, 07:30 ET
Eli Lilly and Company logo.

Lilly to Present New Clinical Data at 75th American Diabetes Association® Scientific Sessions

 New clinical data demonstrating the range of treatment options represented in Lilly's (NYSE: LLY) diabetes portfolio will be presented in 79...

May 14, 2015, 06:00 ET
Eli Lilly and Company logo.

Lilly and Sanford-Burnham Announce Collaboration to Investigate Immunological Therapies

 Eli Lilly and Company (NYSE: LLY) and Sanford-Burnham Medical Research Institute today announced that they will collaborate to discover and...

May 12, 2015, 08:30 ET
Eli Lilly and Company logo

Lilly Announces Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities and the Redemption of Its 6.57% Notes due 2016

Eli Lilly and Company (NYSE: LLY) announced today that it has commenced a cash tender offer for up to $1.6 billion aggregate principal amount (the...

May 11, 2015, 15:14 ET
BioNTech Logo

Lilly and BioNTech Announce Research Collaboration on Novel Cancer Immunotherapies

 Eli Lilly and Company (NYSE:LLY) and BioNTech AG today announced they have entered into a research collaboration to discover novel cancer...

May 06, 2015, 08:00 ET
Eli Lilly and Company logo.

Eli Lilly and Company Reveals Plan for Innovation Center in Cambridge, Massachusetts

Eli Lilly and Company (NYSE: LLY) today announced plans to establish a new drug delivery and device innovation center in Cambridge, Massachusetts...

May 04, 2015, 14:26 ET
Eli Lilly and Company logo.

Lilly Declares Second-Quarter 2015 Dividend

 The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the second quarter of 2015 of $0.50 per share on...

May 04, 2015, 08:00 ET
Eli Lilly and Company logo.

Lilly Releases Corporate Responsibility, Global Health Reports

Eli Lilly and Company (NYSE: LLY) today released two new reports that provide a comprehensive overview of the company's corporate...

May 01, 2015, 13:05 ET
Eli Lilly and Company logo.

Lilly to Participate in Bank of America Merrill Lynch Health Care Conference

Eli Lilly and Company (NYSE: LLY) will attend the Bank of America Merrill Lynch 2015 Health Care Conference on Wednesday, May 13, 2015. Derica...

Apr 28, 2015, 07:00 ET
Eli Lilly and Company logo.

Survey Finds Half of Heart Stent Patients Don't Take Their Oral Antiplatelet Medication As Prescribed

 People with acute coronary syndrome (ACS) who undergo an angioplasty procedure and receive a heart stent are prescribed an oral antiplatelet...

Apr 24, 2015, 16:27 ET
Eli Lilly and Company logo.

Lilly's CYRAMZA® (ramucirumab) Receives Fourth FDA Approval

Eli Lilly and Company (NYSE: LLY) has received its fourth U.S. Food and Drug Administration (FDA) approval for CYRAMZA®...

Apr 23, 2015, 06:25 ET
Eli Lilly and Company logo

Lilly Reports First-Quarter 2015 Results

- Revenue declined 1 percent due to the unfavorable impact of foreign exchange rates and the continuing impact of Cymbalta and Evista...

Apr 20, 2015, 09:00 ET
Eli Lilly and Company logo

Lilly Releases Early-Stage Pipeline Data at AACR Annual Meeting 2015

 Eli Lilly and Company (NYSE: LLY) will present early stage data from several targeted cancer therapies, reflecting Lilly's diverse oncology...

Apr 20, 2015, 08:00 ET
Eli Lilly and Company logo.

Lilly's Ixekizumab Met Primary Endpoint in a Phase 3 Study Investigating the Treatment of Psoriatic Arthritis

Eli Lilly and Company (NYSE: LLY) announced today that the investigational medicine ixekizumab was statistically superior to placebo in the...